Viridian Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/13/2025 | 11.88 M | $227.78 M | 6.25% | 17.89% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 5.76 M | $110.39 M | 19.87% | 8.67% |
| VANGUARD GROUP INC | 02/11/2025 | 4.60 M | $88.09 M | 3.96% | 6.92% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 4.52 M | $86.70 M | 20.58% | 6.81% |
| VR ADVISER, LLC | 02/14/2025 | 3.88 M | $74.43 M | 0.00% | 5.85% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 02/14/2025 | 3.45 M | $66.06 M | 0.00% | 5.19% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 3.33 M | $63.76 M | 32.45% | 5.01% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 2.49 M | $47.79 M | 11.15% | 3.75% |
| COMMODORE CAPITAL LP | 02/14/2025 | 2.40 M | $46.01 M | -5.89% | 3.61% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 2.29 M | $43.84 M | 3.83% | 3.44% |
| NOVO HOLDINGS A/S | 02/14/2025 | 2.25 M | $43.13 M | -5.66% | 3.39% |
| MAVERICK CAPITAL LTD | 02/14/2025 | 2.05 M | $39.37 M | 2.84% | 3.09% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.88 M | $35.96 M | -5.81% | 2.82% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 1.82 M | $34.89 M | -37.15% | 2.74% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.67 M | $32.01 M | 38.59% | 2.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.66 M | $31.81 M | 11.09% | 2.50% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 1.49 M | $28.50 M | -47.15% | 2.24% |
| LOOMIS SAYLES & CO L P | 02/12/2025 | 1.40 M | $26.85 M | 100.00% | 2.11% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.33 M | $25.44 M | 2,847.68% | 2.00% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.25 M | $23.94 M | 21.79% | 1.88% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 1.09 M | $20.85 M | 155.91% | 1.64% |
| VIVO CAPITAL, LLC | 02/13/2025 | 982,576 | $18.84 M | -41.45% | 1.48% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 920,094 | $17.64 M | 24.46% | 1.39% |
| OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 870,000 | $16.68 M | 0.00% | 1.31% |
| WOODLINE PARTNERS LP | 02/14/2025 | 813,647 | $15.60 M | -0.65% | 1.23% |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 779,998 | $14.95 M | 12.84% | 1.17% |
| YIHENG CAPITAL MANAGEMENT, L.P. | 02/11/2025 | 750,261 | $14.38 M | -11.51% | 1.13% |
| GREAT POINT PARTNERS LLC | 02/14/2025 | 750,000 | $14.38 M | 0.00% | 1.13% |
| 5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 736,595 | $14.12 M | 0.00% | 1.11% |
| CANDRIAM S.C.A. | 02/07/2025 | 731,221 | $14.02 M | -2.48% | 1.10% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 681,012 | $13.06 M | 198.19% | 1.03% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 670,600 | $12.86 M | -12.12% | 1.01% |
| CUTTER CAPITAL MANAGEMENT, LP | 02/14/2025 | 628,677 | $12.05 M | 21.21% | 0.95% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 575,070 | $11.02 M | 11.40% | 0.87% |
| FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 518,027 | $9.93 M | 4.67% | 0.78% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 516,800 | $9.91 M | 145.63% | 0.78% |
| UBS GROUP AG | 02/14/2025 | 512,071 | $9.82 M | 504.33% | 0.77% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 481,639 | $9.23 M | -13.99% | 0.73% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 469,949 | $9.01 M | -6.01% | 0.71% |
| LORD, ABBETT & CO. LLC | 02/14/2025 | 459,588 | $8.81 M | 17.25% | 0.69% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 442,070 | $8.47 M | 220.19% | 0.67% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 424,537 | $8.14 M | -11.95% | 0.64% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 02/18/2025 | 423,272 | $8.11 M | -33.14% | 0.64% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 410,440 | $7.87 M | 100.00% | 0.62% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 402,874 | $7.72 M | 6.15% | 0.61% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 379,596 | $7.28 M | -14.18% | 0.57% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 371,200 | $7.12 M | 522.82% | 0.56% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 365,972 | $7.02 M | -45.22% | 0.55% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 335,569 | $6.43 M | -24.56% | 0.51% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 313,787 | $6.02 M | 100.00% | 0.47% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Viridian Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 200 institutional investors and hedge funds held shares of Viridian Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 11.88 M
BlackRock Funding, Inc. /DE: 5.76 M
VANGUARD GROUP INC: 4.6 M
Deep Track Capital, LP: 4.52 M
VR Adviser, LLC: 3.88 M
Fairmount Funds Management LLC: 3.45 M
137.07% of Viridian Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 93.75 M shares in the last 24 months. This purchase volume represents approximately $1.88 B in transactions.